SOTS 2nd Hour: Your Earnings Playbook - from Big Tech to Healthcare, Plus Anthropic Fundraise Details 4/30/26

Summary

From big tech earnings to the Fed's decision to hold rates steady... Carl Quintanilla, Sara Eisen, and David Faber broke down what investors should know this hour - and what it means for the markets - with an all-star cast including Janus Henderson's Global Macro Investing head and one of the street's top big tech analysts. Plus: how AI is changing drug d…

Key takeaways

• Alphabet's cloud business surpassed $20B in quarterly revenue for the first time (up 63% YoY), with AI—especially Gemini Enterprise and TPU sales—now the primary growth driver, validating its hyperscaler capex strategy.
• Anthropic's valuation has more than doubled since February to a potential $900B, driven by explosive revenue growth from ~$10B to ~$35B run rate in under a year, with an IPO potentially as early as Q4 2025.
• Fed Chair Powell signaled he will remain as Fed Governor past his planned retirement due to threats to institutional independence, a historically rare move last seen in 1948 under Marriner Eccles.

Why this matters

The divergence in Big Tech earnings—Alphabet and AWS monetizing AI capex while Meta struggles to show ROI without a cloud business—signals that enterprise AI revenue validation, not just spending scale, is now the primary valuation driver for B2B technology investments.

Entities

Show notes

From big tech earnings to the Fed's decision to hold rates steady... Carl Quintanilla, Sara Eisen, and David Faber broke down what investors should know this hour - and what it means for the markets - with an all-star cast including Janus Henderson's Global Macro Investing head and one of the street's top big tech analysts. Plus: how AI is changing drug discovery with the CEO of Bausch & Lomb, and new CNBC reporting around a staggering new possible valuation for Anthropic. Squawk on the Street D

Themes

• anthropic
• investing